---
document_datetime: 2025-01-06 14:43:37
document_pages: 21
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/azopt-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: azopt-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 11.2342849
conversion_datetime: 2025-12-24 21:35:27.132876
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Azopt

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                 | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IAIN/0080/G          | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - | 18/12/2024                          |                                             | Annex II and PL                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | Not including batch control/testing A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     |           |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| II/0078/G | This was an application for a group of variations. B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place | 12/12/2024 | n/a | B.I.a.1.f |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |     |                      |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------|
| IB/0079/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 06/12/2024 | n/a | A.4 - Administrative |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| or supplier of the AS, starting intermediate used in the manufacturer of a novel A.7 - Administrative change manufacturing sites A.4 - Administrative change and/or address of a manufacturer or supplier of the AS, starting intermediate used in the manufacturer of a novel B.I.a.1.z - Change in the starting material/reagent/intermediate variation B.I.b.1.b - Change in the and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.2.a - Change in test starting material/reagent/intermediate changes to an approved B.I.b.1.d - Change in the and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in the and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.z - Change in the   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | material/intermediate/reagent - Other variation B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure   |            |            |             |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IB/0077 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 16/03/2023 | 16/02/2024 | SmPC and PL |

<div style=\"page-break-after: always\"></div>

| IB/0076           | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 14/10/2022   | n/a        |                 |                                                                                                                                          |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/432/2 02108 | Periodic Safety Update EU Single assessment - brinzolamide                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 22/04/2022   | 24/06/2022 | SmPC and PL     | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/432/202108. |
| IAIN/0074/G       | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release | 12/10/2021   | 24/06/2022 | Annex II and PL |                                                                                                                                          |
| IAIN/0073         | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 12/02/2021   | n/a        |                 |                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

| IB/0072   | B.II.c.1.z - Change in the specification parameters and/or limits of an excipient - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 12/03/2020   | n/a        |                                  |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|
| IB/0071/G | This was an application for a group of variations. A.z - Administrative change - Other variation B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the | 13/05/2019   | n/a        |                                  |
| IA/0070   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 22/06/2018   | 06/06/2019 | SmPC, Annex II, Labelling and PL |

<div style=\"page-break-after: always\"></div>

| T/0069    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 20/03/2018   | 12/04/2018   | SmPC, Labelling and PL   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|
| IB/0068   | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 26/02/2018   | n/a          |                          |
| IB/0067   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 08/01/2018   | n/a          |                          |
| T/0066    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 06/04/2017   | 31/05/2017   | SmPC, Labelling and PL   |
| II/0064/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.2.b - Changes in the manufacturing process of the AS - Substantial change to the manufacturing process of the AS which may have a significant impact on the quality, safety or efficacy of the medicinal product B.I.a.3.a - Change in batch size (including batch size | 18/05/2017   | n/a          |                          |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| ranges) of AS or intermediate increase compared to size B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.1.c - Change in and/or limits of an AS, material/intermediate/reagent specification parameter corresponding test method B.I.b.1.c - Change in and/or limits of an AS, material/intermediate/reagent specification parameter corresponding test method B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter)   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.z - Change in and/or limits of an AS,   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                             |            |            |    |                                   |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-----------------------------------|
| PSUSA/432/2 01608 | Periodic Safety Update EU Single assessment - brinzolamide                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 05/05/2017 | n/a        |    | PRAC Recommendation - maintenance |
| N/0065            | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                  | 21/02/2017 | 31/05/2017 | PL |                                   |
| IB/0063/G         | This was an application for a group of variations. B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting | 13/01/2017 | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate   |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0452   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                    | 28/07/2014 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| II/0059   | Update of sections 4.2, 4.4, 4.6, 4.7 and 4.8 of the SmPC following a review of the available clinical and post-marketing data. The Package Leaflet and Labelling were updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                      | 25/04/2014 | 13/04/2015 | SmPC, Annex II, Labelling and PL | The MAH undertook a review of the available data supporting the safety profile of Azopt eye drops. No new clinical trial data were evaluated for the purpose of this review, which was based on data from previously reported clinical studies and post-marketing experience with the product. Practical instructions about the tamper evident snap collar were also included ('After the cap is removed, if the tamper evident snap collar is loose, remove before using product'). |
| PSUV/0060 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                             | 10/04/2014 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IG/0324   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                     | 22/07/2013 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| N/0056    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                   | 01/07/2013 | 05/03/2014 | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

| IA/0054   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                           | 21/03/2013   | n/a        |                        |                       |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------|
| IG/0274   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                        | 19/03/2013   | 05/03/2014 | SmPC, Labelling and PL |                       |
|           | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system | 06/03/2012   | 15/06/2012 | Annex II               | IG/0149/G             |
| IG/0145   | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer                                                                                                                                    | 09/02/2012   | n/a        |                        |                       |
| IG/0107/G | This was an application for a group of variations. C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of                                                                                                                                      | 19/09/2011   | n/a        |                        | the pharmacovigilance |

<div style=\"page-break-after: always\"></div>

|         | to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD                                                                                            |            |            |          | C.I.9.b - Changes   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------|---------------------|
| IB/0045 | B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the currently approved batch size                                                                                                                                                                                                                                                                                                        | 25/03/2011 | n/a        |          |                     |
| WS/0075 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To replace the current resin which is used for the closures for the drop-trainer packaging system, with two new resins. B.II.e.1.a.3 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Sterile medicinal products and biological/immunological medicinal products | 20/01/2011 | 04/02/2011 |          |                     |
| IG/0039 | C.I.9.i - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) to a DDPS following the assessment of the same DDPS in relation to another medicinal product of the same                                                                                                                                                                                                                                                            | 17/01/2011 | n/a        | Annex II |                     |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     |    |                    |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|--------------------|
| N/0044    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 01/12/2010 | n/a | PL |                    |
| IB/0043/G | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method in test procedure for AS or | 15/09/2010 | n/a |    | B.I.b.2.c - Change |

<div style=\"page-break-after: always\"></div>

|         | changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS                                                                                                                                                                                                                                                                |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0042 | B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products | 21/05/2010 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| R/0039  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                             | 19/11/2009 | 29/01/2010 | SmPC, Annex II, Labelling and PL | Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit risk balance, the CHMP was of the opinion that the quality, safety and efficacy of this medicinal product continued to be adequately and sufficiently demonstrated and therefore considered that the benefit risk profile of Azopt continued to be favourable. The CHMP was also of the opinion that the renewal could be granted with unlimited validity. |
| II/0036 | Additional site for sterilisation of the closures used to manufacture Azopt eye drops. Change(s) to the manufacturing process for the finished product                                                                                                                                                                                                                              | 29/05/2009 | 16/06/2009 |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0035 | Additional site for sterilisation Azopt eye drops.                                                                                                                                                                                                                                                                                                                                  | 29/05/2009 | 16/06/2009 |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|         | Change(s) to the manufacturing process for the finished product                                                                                                                                              |            |            |                        |                                                                                                                                                                                                                                                |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0038 | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold                                                                                                                             | 29/05/2009 | n/a        |                        |                                                                                                                                                                                                                                                |
| IA/0037 | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold                                                                                                                             | 29/05/2009 | n/a        |                        |                                                                                                                                                                                                                                                |
| II/0034 | The Marketing Authorisation Holder applied for the redefinition of the starting material for the active substance. Change(s) to the manufacturing process for the active substance                           | 22/01/2009 | 26/01/2009 |                        |                                                                                                                                                                                                                                                |
| N/0033  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                             | 19/01/2009 | n/a        | Labelling and PL       |                                                                                                                                                                                                                                                |
| II/0030 | Extension of the approved indication to include use of Azopt as 'adjunctive therapy' with prostaglandin analogues. Extension of Indication                                                                   | 24/04/2008 | 20/06/2008 | SmPC, Annex II and PL  | Please refer to Assessment Report: Azopt-H-C-267-II-30                                                                                                                                                                                         |
| IA/0032 | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold                                                                                                                             | 04/06/2008 | n/a        |                        |                                                                                                                                                                                                                                                |
| II/0029 | Update of section 4.8 of the Summary of Product Characteristics (SPC) based on safety review in the light of the full clinical study experience to-date. The Package Leaflet (PL) is updated accordingly.The | 18/10/2007 | 30/11/2007 | SmPC, Labelling and PL | This variation application was submitted in order to update section 4.8 (Undesirable effects) of the SPC to reflect the data from 8 clinical trials completed since the approval of Azopt. In addition, the product information was updated in |

<div style=\"page-break-after: always\"></div>

|         | opportunity is also taken to change the SPC in order to comply with the current SPC guidelines and MedDRA terminology. Additionally, the product information is amended to reflect current QRD requirements. Update of Summary of Product Characteristics, Labelling and Package Leaflet                            |            |            |                       | accordance with the current QRD requirements.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0031 | Quality changes                                                                                                                                                                                                                                                                                                     | 18/10/2007 | 23/10/2007 |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| II/0026 | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                     | 21/06/2007 | 22/06/2007 |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| II/0025 | Update of Summary of Product Characteristics and Package Leaflet to include information on the limited paediatric data of Azopt. Amendments have been made to sections 4.2, 4.4, 4.8 and 5.1 of the SPC and to the Package Leaflet as appropriate. Update of Summary of Product Characteristics and Package Leaflet | 26/04/2007 | 13/06/2007 | SmPC, Annex II and PL | A clinical trial was conducted with AZOPT in 32 paediatric patients less than 6 years of age, diagnosed with glaucoma or ocular hypertension Results from the study show that in children not previously treated, the efficacy of Azopt is similar to the one in adults. However, in children who received prior treatment with Intra Ocular Pressure (IOP) lowering medication, the mean IOP changes from baseline did not decrease, and in fact a slight increase was observed in Azopt group. |
| IA/0028 | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold                                                                                                                                                                                                                                    | 11/04/2007 | n/a        |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| IA/0027 | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.)                                                                                                                                                                                                                  | 11/04/2007 | n/a        |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| II/0024 | Update of or change(s) to the pharmaceutical documentation                                                                                                                                                                                                                                                          | 24/01/2007 | 20/02/2007 | Annex II and PL       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

| IA/0023   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 16/08/2006   | n/a   |
|-----------|------------------------------------------------------------------------------------|--------------|-------|
| IA/0022   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 16/08/2006   | n/a   |
| IA/0021   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 16/08/2006   | n/a   |
| IA/0020   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 31/07/2006   | n/a   |
| IA/0019   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 31/07/2006   | n/a   |
| IA/0018   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 31/07/2006   | n/a   |
| IA/0017   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 31/07/2006   | n/a   |
| IA/0016   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 31/07/2006   | n/a   |
| IA/0015   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 31/07/2006   | n/a   |
| IA/0014   | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold   | 31/07/2006   | n/a   |

<div style=\"page-break-after: always\"></div>

|         | IA_11_a_Change in batch size of active substance or intermediate - up to 10-fold                                                                                                                                                                                | 31/07/2006   | n/a        |                                  | IA/0013            |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|--------------------|
| IB/0012 | IB_14_b_Change in manuf. of active substance without Ph. Eur. certificate - new manufacturer                                                                                                                                                                    | 06/06/2006   | n/a        |                                  |                    |
| R/0011  | Renewal of the marketing authorisation.                                                                                                                                                                                                                         | 17/02/2005   | 02/06/2005 | SmPC, Annex II, Labelling and PL |                    |
| N/0008  | MAH applied for the inclusio of additional local representatives of the MAH for all new Members States and of an electronic contact address for the Swedish local representative. Minor change in labelling or package leaflet not SPC (Art. 61.3 Notification) | 13/05/2004   | n/a        | Labelling and PL                 | connected with the |
| N/0007  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                | 07/10/2002   | 12/11/2002 | PL                               |                    |
| I/0006  | 16_Change in the batch size of finished product                                                                                                                                                                                                                 | 24/06/2002   | 28/06/2002 |                                  |                    |
| I/0005  | 12_Minor change of manufacturing process of the active substance                                                                                                                                                                                                | 08/05/2002   | 23/05/2002 |                                  |                    |
| I/0004  | 12_Minor change of manufacturing process of the active substance                                                                                                                                                                                                | 14/03/2002   | 18/03/2002 |                                  |                    |
| I/0003  | 12_Minor change of manufacturing process of the active substance                                                                                                                                                                                                | 12/11/2001   | 15/02/2002 |                                  |                    |

<div style=\"page-break-after: always\"></div>

| I/0002   | 11b_Change in supplier of an intermediate compound used in manufacture of the active substance   | 12/11/2001   | 15/02/2002   |                                  |
|----------|--------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|
| I/0001   | 30_Change in pack size for a medicinal product                                                   | 05/04/2000   | 16/11/2000   | SmPC, Annex II, Labelling and PL |